Literature DB >> 11575783

Synthesis and biological evaluation of vancomycin dimers with potent activity against vancomycin-resistant bacteria: target-accelerated combinatorial synthesis.

K C Nicolaou1, R Hughes, S Y Cho, N Winssinger, H Labischinski, R Endermann.   

Abstract

Based on the notion that dimerization and/or variation of amino acid 1 of vancomycin could potentially enhance biological activity, a series of synthetic and chemical biology studies were undertaken in order to discover potent antibacterial agents. Herein we describe two ligation methods (disulfide formation and olefin metathesis) for dimerizing vancomycin derivatives and applications of target-accelerated combinatorial synthesis (e.g. combinatorial synthesis in the presence of vancomycin's target Ac2-L-Lys-D-Ala-D-Ala) to generate libraries of vancomycin dimers. Screening of these compound libraries led to the identification of a number of highly potent antibiotics effective against vancomycin-suspectible, vancomycin-intermediate resistant and, most significantly, vancomycin-resistant bacteria.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11575783     DOI: 10.1002/1521-3765(20010903)7:17<3824::aid-chem3824>3.0.co;2-1

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  22 in total

Review 1.  The essence of total synthesis.

Authors:  K C Nicolaou; Scott A Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-09       Impact factor: 11.205

Review 2.  Constructing molecular complexity and diversity: total synthesis of natural products of biological and medicinal importance.

Authors:  K C Nicolaou; Christopher R H Hale; Christian Nilewski; Heraklidia A Ioannidou
Journal:  Chem Soc Rev       Date:  2012-06-28       Impact factor: 54.564

3.  A stepwise dechlorination/cross-coupling strategy to diversify the vancomycin 'in-chloride'.

Authors:  Tyler J Wadzinski; Katherine D Gea; Scott J Miller
Journal:  Bioorg Med Chem Lett       Date:  2015-12-11       Impact factor: 2.823

Review 4.  Recent advances in the chemistry and biology of naturally occurring antibiotics.

Authors:  K C Nicolaou; Jason S Chen; David J Edmonds; Anthony A Estrada
Journal:  Angew Chem Int Ed Engl       Date:  2009       Impact factor: 15.336

Review 5.  Approved Glycopeptide Antibacterial Drugs: Mechanism of Action and Resistance.

Authors:  Daina Zeng; Dmitri Debabov; Theresa L Hartsell; Raul J Cano; Stacy Adams; Jessica A Schuyler; Ronald McMillan; John L Pace
Journal:  Cold Spring Harb Perspect Med       Date:  2016-12-01       Impact factor: 6.915

6.  Structural variations of the cell wall precursor lipid II and their influence on binding and activity of the lipoglycopeptide antibiotic oritavancin.

Authors:  Daniela Münch; Ina Engels; Anna Müller; Katrin Reder-Christ; Hildegard Falkenstein-Paul; Gabriele Bierbaum; Fabian Grein; Gerd Bendas; Hans-Georg Sahl; Tanja Schneider
Journal:  Antimicrob Agents Chemother       Date:  2014-11-17       Impact factor: 5.191

7.  Bcl-XL-templated assembly of its own protein-protein interaction modulator from fragments decorated with thio acids and sulfonyl azides.

Authors:  Xiangdong Hu; Jiazhi Sun; Hong-Gang Wang; Roman Manetsch
Journal:  J Am Chem Soc       Date:  2008-09-24       Impact factor: 15.419

8.  Vancomycin forms ligand-mediated supramolecular complexes.

Authors:  Patrick J Loll; Ariss Derhovanessian; Maxim V Shapovalov; Jeffrey Kaplan; Lin Yang; Paul H Axelsen
Journal:  J Mol Biol       Date:  2008-11-01       Impact factor: 5.469

Review 9.  Glycopeptide antibiotics: from conventional molecules to new derivatives.

Authors:  Françoise Van Bambeke; Yves Van Laethem; Patrice Courvalin; Paul M Tulkens
Journal:  Drugs       Date:  2004       Impact factor: 9.546

10.  Polymerizable vancomycin derivatives for bactericidal biomaterial surface modification: structure-function evaluation.

Authors:  McKinley C Lawson; Richard Shoemaker; Kevin B Hoth; Christopher N Bowman; Kristi S Anseth
Journal:  Biomacromolecules       Date:  2009-08-10       Impact factor: 6.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.